Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

Nicola Stefano Fracchiolla, Stefano Luminari, Luca Baldini, Luigia Lombardi, Anna Teresa Maiolo, Antonino Neri, FGFR3 Gene Mutations Associated With Human Skeletal Disorders Occur Rarely in Multiple Myeloma Blood. ,vol. 92, pp. 2987- 2989 ,(1998) , 10.1182/BLOOD.V92.8.2987

Raffaella Richelda, Domenica Ronchetti, Luca Baldini, Lilla Cro, Luigi Viggiano, Rosalia Marzella, Mariano Rocchi, Takemi Otsuki, Luigia Lombardi, Anna Teresa Maiolo, Antonino Neri, A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood. ,vol. 90, pp. 4062- 4070 ,(1997) , 10.1182/BLOOD.V90.10.4062

Marta Chesi, Elena Nardini, Robert S.C. Lim, Kerrington D. Smith, W. Michael Kuehl, P. Leif Bergsagel, The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3 and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts Blood. ,vol. 92, pp. 3025- 3034 ,(1998) , 10.1182/BLOOD.V92.9.3025

Daniel K. Podolsky, Ian Rosenberg, Shoji Tsunekawa, Michelle deBeaumont, Bernadette Murgue, Bernadette Murgue, Identification of a Novel Variant Form of Fibroblast Growth Factor Receptor 3 (FGFR3 IIIb) in Human Colonic Epithelium Cancer Research. ,vol. 54, pp. 5206- 5211 ,(1994)

Michael C. Naski, Qing Wang, Jingsong Xu, David M. Ornitz, Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genetics. ,vol. 13, pp. 233- 237 ,(1996) , 10.1038/NG0696-233

Jennifer S. Colvin, Barbara A. Bohne, Gary W. Harding, Donald G. McEwen, David M. Ornitz, Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genetics. ,vol. 12, pp. 390- 397 ,(1996) , 10.1038/NG0496-390

Marta Chesi, Elena Nardini, Leslie A. Brents, Evelin Schröck, Thomas Ried, W. Michael Kuehl, P. Leif Bergsagel, Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics. ,vol. 16, pp. 260- 264 ,(1997) , 10.1038/NG0797-260

M Webster, FGFR activation in skeletal disorders: too much of a good thing Trends in Genetics. ,vol. 13, pp. 178- 182 ,(1997) , 10.1016/S0168-9525(97)01131-1

Chuxia Deng, Anthony Wynshaw-Boris, Fen Zhou, Ann Kuo, Philip Leder, Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth Cell. ,vol. 84, pp. 911- 921 ,(1996) , 10.1016/S0092-8674(00)81069-7

Patricia L. Tavormina, Gary A. Bellus, Melanie K. Webster, Michael J. Bamshad, Alexander E. Fraley, Iain McIntosh, Jinny Szabo, Wen Jiang, Ethylin W. Jabs, William R. Wilcox, John J. Wasmuth, Daniel J. Donoghue, Leslie M. Thompson, Clair A. Francomano, A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. American Journal of Human Genetics. ,vol. 64, pp. 722- 731 ,(1999) , 10.1086/302275